Topic

Mapp Biopharmaceuticals

1 recent story · updated continuously

Stat

Experimental Ebola Treatment MBP-134 Approved for High-Risk Americans Amid Outbreak

healthJust now
Experimental Ebola Treatment MBP-134 Approved for High-Risk Americans Amid Outbreak